HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Yale Mitchel Selected Research

Withholding Treatment

1/2014Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart disease.
10/2011Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Yale Mitchel Research Topics

Disease

8Coronary Disease (Coronary Heart Disease)
01/2015 - 06/2004
4Dyslipidemias (Dyslipidemia)
05/2012 - 02/2009
3Cardiovascular Diseases (Cardiovascular Disease)
05/2015 - 07/2009
3Flushing
05/2012 - 10/2008
3Hypercholesterolemia
10/2011 - 06/2006
2Hyperlipidemias (Hyperlipidemia)
10/2011 - 02/2009
1Diarrhea
05/2015
1Nausea
05/2015

Drug/Important Bio-Agent (IBA)

7anacetrapibIBA
01/2015 - 02/2009
6Cholesterol Ester Transfer ProteinsIBA
05/2015 - 02/2009
6LDL CholesterolIBA
01/2015 - 06/2004
5Niacin (Nicotinic Acid)FDA LinkGeneric
05/2015 - 10/2008
5HDL CholesterolIBA
01/2015 - 06/2006
5Simvastatin (Zocor)FDA LinkGeneric
05/2012 - 06/2004
4ezetimibe (Zetia)FDA Link
06/2006 - 06/2004
3Lipoproteins (Lipoprotein)IBA
01/2014 - 07/2009
3MK-0524IBA
05/2012 - 07/2009
2LipidsIBA
01/2014 - 10/2008
2atorvastatin (Lipitor)FDA Link
10/2011 - 02/2009
1Blood Glucose (Blood Sugar)IBA
05/2015
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
07/2009
1Nonesterified Fatty Acids (NEFA)IBA
10/2008
13- (1H- tetrazol- 5- yl)- 1,4,5,6- tetrahydrocyclopentapyrazoleIBA
10/2008
1Apolipoproteins B (ApoB)IBA
06/2006
1C-Reactive ProteinIBA
06/2006
1ApolipoproteinsIBA
06/2006
1Triglycerides (Triacylglycerol)IBA
06/2006
1CholesterolIBA
06/2004

Therapy/Procedure

2Withholding Treatment
01/2014 - 10/2011